An oligonucleotide carrier based on β-1,3-glucans

Kazuo Sakurai, Seiji Shinkai

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

6 Conclusions: This study demonstrates the potential of SPG as an oligonucleotide carrier, for example, in antisense and CpG DNAs. The most distinguishing feature of this carrier compared to other cation types is that the driving force of the complexation is hydrogen bonds instead of electrostatic forces. Therefore, the total charge of the SPG/nucleotide complex is negative and there is no DNA-compaction problem in this system. Using chemically modified SPG, the antisense effect and CpG immunostimulatory response can be enhanced.

Original languageEnglish
Title of host publicationNon-viral Gene Therapy
Subtitle of host publicationGene Design and Delivery
PublisherSpringer-Verlag Tokyo
Pages103-117
Number of pages15
ISBN (Electronic)9784431278795
ISBN (Print)4431251227, 9784431251224
DOIs
Publication statusPublished - Jan 1 2005

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'An oligonucleotide carrier based on β-1,3-glucans'. Together they form a unique fingerprint.

  • Cite this

    Sakurai, K., & Shinkai, S. (2005). An oligonucleotide carrier based on β-1,3-glucans. In Non-viral Gene Therapy: Gene Design and Delivery (pp. 103-117). Springer-Verlag Tokyo. https://doi.org/10.1007/4-431-27879-6_9